These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2139943)

  • 1. [An imipenem-cilastatin combination in the treatment of infection at general intensive care units].
    Gouin F
    Presse Med; 1990 Apr; 19(13):620-4. PubMed ID: 2139943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of imipenem-cilastatin at intensive care units].
    Leroy J
    Presse Med; 1990 Apr; 19(13):613-5. PubMed ID: 2139941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Imipenem-cilastatin in infections].
    Armengaud M
    Presse Med; 1990 Apr; 19(13):629-33. PubMed ID: 2139945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of an imipenem-cilastatin combination in surgery and surgical care units].
    Bouletreau P
    Presse Med; 1990 Apr; 19(13):616-9. PubMed ID: 2139942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An imipenem-cilastatin combination in the treatment of infection in hemato-oncology].
    Espinouse D
    Presse Med; 1990 Apr; 19(13):625-8. PubMed ID: 2139944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospective, randomized, controlled study of imipenem-cilastatin versus cefotaxime-amikacin in the treatment of lower respiratory tract infection and septicemia at intensive care units].
    Mouton Y; Deboscker Y; Bazin C; Fourrier F; Moulront S; Philippon A; Socolovsky C; Suinat JL; Tondriaux A
    Presse Med; 1990 Apr; 19(13):607-12. PubMed ID: 2139940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of bronchopulmonary infections in patients during artificial respiration with imipenem/cilastatin].
    Unertl K; Lenhart FP; Ruckdeschel G
    Immun Infekt; 1986 Nov; 14(6):229-31. PubMed ID: 3100428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meropenem versus imipenem/cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit.
    Verwaest C;
    Clin Microbiol Infect; 2000 Jun; 6(6):294-302. PubMed ID: 11168137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
    West M; Boulanger BR; Fogarty C; Tennenberg A; Wiesinger B; Oross M; Wu SC; Fowler C; Morgan N; Kahn JB
    Clin Ther; 2003 Feb; 25(2):485-506. PubMed ID: 12749509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of imipenem/cilastatin in the therapy of severe infections in high-risk patients.
    Cristiano P
    Drugs Exp Clin Res; 1989; 15(1):17-20. PubMed ID: 2743870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
    Cakmakci M; Stern A; Schilling J; Christen D; Roggo A; Geroulanos S
    Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group.
    Norrby SR; Finch RG; Glauser M
    J Antimicrob Chemother; 1993 Jun; 31(6):927-37. PubMed ID: 8360130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antimicrobial activity of imipenem/cilastatin and its treatment in critical ill patients with polymicrobial and mixed infection.
    Leu HS; Wu JL
    Changgeng Yi Xue Za Zhi; 1993 Sep; 16(3):154-63. PubMed ID: 8221288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of respiratory tract infections with imipenem/cilastatin in critical patients with respiratory insufficiency].
    Unertl K; Ruckdeschel G; Forst H; Lenhart FP
    Infection; 1986; 14 Suppl 2():S176-80. PubMed ID: 3759253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic equivalence of generic imipenem/cilastatin for therapy of infections at Siriraj Hospital.
    Piyasirisilp S; Premprawat W; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S117-25. PubMed ID: 20364566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized controlled clinical study on biapenem and imipenem/cilastatin injection in the treatment of respiratory and urinary tract infections.
    Jia B; Lu P; Huang W; Li C; Huang A; Zhou X; Zhang W; Wu G; Zhang G
    Chemotherapy; 2010; 56(4):285-90. PubMed ID: 20714145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
    Garbino J; Villiger P; Caviezel A; Matulionyte R; Uckay I; Morel P; Lew D
    Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evidence-based medicine, health costs and treatment of intra-abdominal infection].
    Badía X; Brosa M; Tellado JM
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():86-94. PubMed ID: 10605193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections: results of a prospective, randomized, multicentre trial.
    Basoli A; Meli EZ; Mazzocchi P; Speranza V
    Scand J Infect Dis; 1997; 29(5):503-8. PubMed ID: 9435041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection.
    Lucasti C; Vasile L; Sandesc D; Venskutonis D; McLeroth P; Lala M; Rizk ML; Brown ML; Losada MC; Pedley A; Kartsonis NA; Paschke A
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6234-43. PubMed ID: 27503659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.